It is known that circulating Lp-PLA2 activity is derived from atherosclerotic plaque cells, however our study subjects had not carried cardiovascular disease including atherosclerosis or other chronic diseases (i.e. diabetes, or dyslipidemia). The gene discussed is PLA2G7; the disease is metabolic syndrome.